Search

everythinglearnresearchcommunity

for

Search:↓

Overexpressing PKCepsilon in mice reduces papillomas but increases carcinomas.

Certain gene variations in EGF and EGFR may increase the risk of alopecia areata in Koreans.

Gefitinib treatment led to unexpected hair growth in two lung cancer patients.

A new keratin gene was found in mice, explaining hair growth.

The extracellular matrix affects where tumors can start in the body.

Increasing m6A levels can improve skin cell growth and wound healing.

Antizyme reduces tumor growth and normalizes skin cell development affected by MEK.

Mutant MK6a transgenes in mice cause blistering, hair loss, and potential human alopecia.

Increased EGFR gene variations may predict chemotherapy outcomes in small cell lung cancer patients.

Epidermal growth factor helps hair recover after chemotherapy.

A rare EGFR mutation in newborns leads to severe health issues and early death.

Y27632 increases cell growth through EGFR signaling, not ROCK1/2.

Epiregulin can help hair grow and may be useful for treating hair loss.

Targeted cancer therapies can cause skin side effects, but activating SOS in the skin may help reduce them.

Skin side effects from CDK4/6 inhibitors in breast cancer patients are generally mild and treatable, allowing most patients to continue treatment.

EGFR helps hair follicles transition properly by controlling Stathmin levels.

Oncogenic melanocyte stem cells can develop into melanoma similar to human cases.

Inhibiting AP-1 changes skin tumor types and affects tumor cell identity.

mEphA1 receptor tyrosine kinase is important for skin and hair development and may play a role in certain diseases.

The risk of skin tumors becoming malignant depends on the specific skin cell type affected.

Colorectal cancer's ability to spread is due to changes in many genes, not just one.

EGF receptor is crucial for skin health and its inhibitors can cause skin rashes.

Epidermal Growth Factor helps hair follicle cells grow and move by activating a specific cell signaling pathway.

Overexpression of HDGF in melanocytes does not cause cancer.

Egfl6 is not needed for zebrafish face development.

Inhibiting AP-1 changes skin tumor types and affects tumor cell identity.

AP-1 controls tumor cell type by affecting key signaling pathways.

A specific hair protein variant increases the spread of breast cancer and is linked to worse survival rates.

Erythematous papulopustular eruptions in cancer patients using EGFR inhibitors show specific skin changes that vary with severity and treatment type.